167 related articles for article (PubMed ID: 23554861)
1. Interleukin-27 signaling promotes immunity against endogenously arising murine tumors.
Natividad KD; Junankar SR; Mohd Redzwan N; Nair R; Wirasinha RC; King C; Brink R; Swarbrick A; Batten M
PLoS One; 2013; 8(3):e57469. PubMed ID: 23554861
[TBL] [Abstract][Full Text] [Related]
2. T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response.
Aragoneses-Fenoll L; Ojeda G; Montes-Casado M; Acosta-Ampudia Y; Dianzani U; Portolés P; Rojo JM
Front Immunol; 2018; 9():332. PubMed ID: 29535720
[TBL] [Abstract][Full Text] [Related]
3. Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.
Belle L; Agle K; Zhou V; Yin-Yuan C; Komorowski R; Eastwood D; Logan B; Sun J; Ghilardi N; Cua D; Williams CB; Gaignage M; Marillier R; van Snick J; Drobyski WR
Blood; 2016 Oct; 128(16):2068-2082. PubMed ID: 27488350
[TBL] [Abstract][Full Text] [Related]
4. SA-4-1BBL costimulation inhibits conversion of conventional CD4+ T cells into CD4+ FoxP3+ T regulatory cells by production of IFN-γ.
Madireddi S; Schabowsky RH; Srivastava AK; Sharma RK; Yolcu ES; Shirwan H
PLoS One; 2012; 7(8):e42459. PubMed ID: 22870329
[TBL] [Abstract][Full Text] [Related]
5. Endogenous IL-21 restricts CD8+ T cell expansion and is not required for tumor immunity.
Søndergaard H; Coquet JM; Uldrich AP; McLaughlin N; Godfrey DI; Sivakumar PV; Skak K; Smyth MJ
J Immunol; 2009 Dec; 183(11):7326-36. PubMed ID: 19915059
[TBL] [Abstract][Full Text] [Related]
6. Essential role for IL-27 receptor signaling in prevention of Th1-mediated immunopathology during malaria infection.
Findlay EG; Greig R; Stumhofer JS; Hafalla JC; de Souza JB; Saris CJ; Hunter CA; Riley EM; Couper KN
J Immunol; 2010 Aug; 185(4):2482-92. PubMed ID: 20631310
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection.
Torrado E; Fountain JJ; Liao M; Tighe M; Reiley WW; Lai RP; Meintjes G; Pearl JE; Chen X; Zak DE; Thompson EG; Aderem A; Ghilardi N; Solache A; McKinstry KK; Strutt TM; Wilkinson RJ; Swain SL; Cooper AM
J Exp Med; 2015 Aug; 212(9):1449-63. PubMed ID: 26282876
[TBL] [Abstract][Full Text] [Related]
8. Increased interleukin-10 production by ASC-deficient CD4+ T cells impairs bystander T-cell proliferation.
Narayan S; Kolly L; So A; Busso N
Immunology; 2011 Sep; 134(1):33-40. PubMed ID: 21718313
[TBL] [Abstract][Full Text] [Related]
9. Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent.
Ostrand-Rosenberg S; Clements VK; Terabe M; Park JM; Berzofsky JA; Dissanayake SK
J Immunol; 2002 Nov; 169(10):5796-804. PubMed ID: 12421960
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment.
Kryczek I; Wei S; Zou L; Altuwaijri S; Szeliga W; Kolls J; Chang A; Zou W
J Immunol; 2007 Jun; 178(11):6730-3. PubMed ID: 17513719
[TBL] [Abstract][Full Text] [Related]
11. Interleukin (IL)-21-independent pathogen-specific CD8+ T-cell expansion, and IL-21-dependent suppression of CD4+ T-cell IL-17 production.
Ertelt JM; Johanns TM; Rowe JH; Way SS
Immunology; 2010 Oct; 131(2):183-91. PubMed ID: 20465570
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
Søndergaard H; Galsgaard ED; Bartholomaeussen M; Straten PT; Odum N; Skak K
J Immunother; 2010 Apr; 33(3):236-49. PubMed ID: 20445344
[TBL] [Abstract][Full Text] [Related]
14. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells.
Batten M; Ramamoorthi N; Kljavin NM; Ma CS; Cox JH; Dengler HS; Danilenko DM; Caplazi P; Wong M; Fulcher DA; Cook MC; King C; Tangye SG; de Sauvage FJ; Ghilardi N
J Exp Med; 2010 Dec; 207(13):2895-906. PubMed ID: 21098093
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response.
Apte SH; Groves P; Olver S; Baz A; Doolan DL; Kelso A; Kienzle N
J Immunol; 2010 Jul; 185(2):998-1004. PubMed ID: 20562261
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.
Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R
J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391
[TBL] [Abstract][Full Text] [Related]
17. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells.
Xia S; Wei J; Wang J; Sun H; Zheng W; Li Y; Sun Y; Zhao H; Zhang S; Wen T; Zhou X; Gao JX; Wang P; Wu Z; Zhao L; Yin Z
J Leukoc Biol; 2014 May; 95(5):733-742. PubMed ID: 24443555
[TBL] [Abstract][Full Text] [Related]
18. Treg-Cell-Derived IL-35-Coated Extracellular Vesicles Promote Infectious Tolerance.
Sullivan JA; Tomita Y; Jankowska-Gan E; Lema DA; Arvedson MP; Nair A; Bracamonte-Baran W; Zhou Y; Meyer KK; Zhong W; Sawant DV; Szymczak-Workman AL; Zhang Q; Workman CJ; Hong S; Vignali DAA; Burlingham WJ
Cell Rep; 2020 Jan; 30(4):1039-1051.e5. PubMed ID: 31995748
[TBL] [Abstract][Full Text] [Related]
19. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
20. IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet.
Siebler J; Wirtz S; Weigmann B; Atreya I; Schmitt E; Kreft A; Galle PR; Neurath MF
Gastroenterology; 2007 Jan; 132(1):358-71. PubMed ID: 17241885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
